Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: audit pharma

  • Home
  • audit pharma
  • Page 59
Quality Assurance under GMP

Review Timelines and Their Impact on Compliance

Review Timelines and Their Impact on Compliance Evaluating the Effect of Review Timelines on Compliance…
GMP Audits and Inspections

Site response priorities after WHO inspection findings

Site response priorities after WHO inspection findings Addressing Findings from WHO Inspections: Priority Responses for…
GMP Audits and Inspections

Observation trends in WHO inspections for manufacturing facilities

Observation trends in WHO inspections for manufacturing facilities Trends in Observations during WHO Inspections of…
Quality Assurance under GMP

Integration of Change Control with CAPA Systems

Integration of Change Control with CAPA Systems Harmonizing Change Control and CAPA Systems in the…
GMP Audits and Inspections

Failure to manage change control under WHO prequalification expectations

Failure to manage change control under WHO prequalification expectations Addressing Change Control Challenges in Line…
Quality Assurance under GMP

Regulatory Expectations for QA Approval in Change Management

Regulatory Expectations for QA Approval in Change Management Understanding Regulatory Requirements for Quality Assurance in…
GMP Audits and Inspections

Deficiencies in training and competency identified during WHO inspections

Deficiencies in training and competency identified during WHO inspections Identifying Training and Competency Deficiencies during…
Quality Assurance under GMP

Documentation Errors in Change Control Records

Documentation Errors in Change Control Records Understanding Documentation Errors in Change Control Management Change control…
GMP Audits and Inspections

Handling inspector requests during WHO prequalification audits

Handling inspector requests during WHO prequalification audits Effectively Addressing Inspector Requests During WHO Prequalification Audits…
Quality Assurance under GMP

Deficiencies in Change Impact Assessment During Audits

Deficiencies in Change Impact Assessment During Audits Identifying Weaknesses in Change Impact Assessments During Pharmaceutical…

Posts pagination

Previous 1 … 58 59 60 … 82 Next

Recent Posts

  • Weak Integration of Laboratory Practices with Quality Systems
  • Regulatory Risks from Weak QA Governance Systems
  • Documentation Gaps in GLP and GMP Records
  • Audit Observations Related to QA Oversight Failures
  • Failure to Align Lab Practices with Regulatory Expectations

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Uncategorized
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.